FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

9727811000001107: Amphotericin (lipid formulation) 50mg/10ml suspension for injection vials 10 vial (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 17-Oct 2012. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    31389101000001113 Amphotericin (lipid formulation) 50mg/10ml suspension for injection vials 10 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    44203401000001119 Amphotericin B (lipid formulation) 50mg/10ml suspension for injection vials 10 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Amphotericin (lipid formulation) 50mg/10ml suspension for injection vials 10 vial Is a Virtual medicinal product pack false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg/10ml suspension for injection vials 10 vial Is pack of Amphotericin (lipid formulation) 50mg/10ml suspension for injection vials false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg/10ml suspension for injection vials 10 vial Has active ingredient Amphotericin B liposome false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg/10ml suspension for injection vials 10 vial Is pack of Amphotericin (lipid formulation) 5mg/mL suspension for injection 10mL vial false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg/10ml suspension for injection vials 10 vial VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg/10ml suspension for injection vials 10 vial VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg/10ml suspension for injection vials 10 vial Has manufactured dose form Conventional release suspension for injection false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg/10ml suspension for injection vials 10 vial Has VMP Amphotericin (lipid formulation) 5mg/mL suspension for injection 10mL vial false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg/10ml suspension for injection vials 10 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Amphotericin false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg/10ml suspension for injection vials 10 vial Has specific active ingredient Amphotericin phospholipid complex false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg/10ml suspension for injection vials 10 vial Has dispensed dose form Conventional release suspension for injection false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg/10ml suspension for injection vials 10 vial VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Abelcet 50mg/10ml suspension for injection vials (Zeneus Pharma) 10 vial 10 x 10ml vials Is a False Amphotericin (lipid formulation) 50mg/10ml suspension for injection vials 10 vial Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start